Needham reiterated coverage on Collegium Pharmaceutical with a new price target
$COLL
Biotechnology: Pharmaceutical Preparations
Health Care
Needham reiterated coverage of Collegium Pharmaceutical with a rating of Buy and set a new price target of $36.00 from $35.00 previously